Understanding the Lived Experiences of Patients Undergoing Surgery for Colorectal Cancer Peritoneal Metastases
- 1 day ago
- 2 min read
Iugai S, Gushchin V, King MC, Copeland A, Wach M, Derby J, Kovalik V, Falla-Zuniga LF, Uzhegova K, Studeman K, Nieroda C, Choudry H, Sardi A. Clinical characteristics and outcomes of patients with goblet cell adenocarcinoma of the appendix treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC): A multicenter cohort study. Eur J Surg Oncol. 2026 Feb 20;52(4):111489. doi: 10.1016/j.ejso.2026.111489. Epub ahead of print. PMID: 41740516.
Why This Study Matters
For some people with colorectal cancer that has spread to the lining of the abdomen (called peritoneal metastases), treatment may include cytoreductive surgery (CRS), often combined with HIPEC. While many studies focus on survival rates or surgical outcomes, less is known about how patients and caregivers actually experience this complex treatment journey.
This study aimed to better understand the real-world emotional, physical, and practical experiences of patients and their care partners before, during, and after CRS treatment.
What Researchers Did
Researchers conducted in-depth interviews with patients who underwent cytoreductive surgery for colorectal peritoneal metastases and with their caregivers. Using qualitative analysis, they explored common themes related to decision-making, recovery, and long-term life impacts.
Key Findings
1. The Path to Surgery Is Often Difficult
Many patients described long and challenging journeys before reaching a specialized center capable of offering CRS. Participants reported:
Delays in diagnosis
Limited awareness of treatment options
The need for strong self-advocacy to access expert care
Patients frequently felt they had to actively search for information and referrals themselves.
2. Decision-Making Is Complex and Emotional
Choosing to undergo CRS was described as balancing:
Hope for longer survival or cure
Fear of complications
Uncertainty about recovery and quality of life
Caregivers played a major role in helping patients process information and make treatment decisions.
3. Recovery Is More Demanding Than Expected
Participants emphasized that recovery from CRS is long and unpredictable, involving:
Physical weakness and fatigue
Emotional adjustment
Changes in independence and daily routines
Many patients felt unprepared for how extended recovery would be compared with other cancer treatments.
4. Caregivers Experience Significant Impact
Care partners described substantial emotional and practical burdens, including caregiving responsibilities, stress, and lifestyle disruption. Despite this, many also reported a strong sense of purpose and resilience.
5. Life After Surgery Often Brings Perspective Shifts
Following treatment, patients commonly reported reassessing priorities, relationships, and goals. Survivorship was described not simply as returning to normal, but adapting to a “new normal.”
What This Means for Patients
This research highlights that successful treatment involves more than surgery alone. Patients considering CRS may benefit from:
Early referral to experienced peritoneal surface malignancy centers
Clear expectations about recovery timelines
Strong caregiver and community support
Access to decision-making resources and survivorship guidance
Understanding patient experiences can help healthcare teams better prepare individuals and families for the realities of treatment.
Studies like this reinforce an important message: education, support, and shared decision-making are essential parts of care for people facing colorectal cancer with peritoneal metastases. As treatment options expand, ensuring patients feel informed and supported throughout the journey remains just as important as clinical outcomes.
